Commerce Bank Sells 4,570 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Commerce Bank decreased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 163,818 shares of the medical device company’s stock after selling 4,570 shares during the quarter. Commerce Bank’s holdings in Cooper Companies were worth $18,076,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of COO. Innealta Capital LLC bought a new position in Cooper Companies in the second quarter valued at approximately $25,000. Ashton Thomas Securities LLC bought a new position in Cooper Companies in the third quarter valued at approximately $25,000. Covestor Ltd lifted its stake in Cooper Companies by 305.9% in the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after buying an additional 208 shares in the last quarter. Crewe Advisors LLC lifted its stake in Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after buying an additional 252 shares in the last quarter. Finally, Tortoise Investment Management LLC lifted its stake in Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after buying an additional 169 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on COO. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday. Piper Sandler lifted their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, Robert W. Baird boosted their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Trading Up 0.0 %

Shares of Cooper Companies stock opened at $99.08 on Thursday. The firm has a 50-day moving average of $106.29 and a 200-day moving average of $98.19. The stock has a market cap of $19.73 billion, a PE ratio of 55.04, a PEG ratio of 2.15 and a beta of 0.99. The Cooper Companies, Inc. has a 52-week low of $82.21 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The company had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. Cooper Companies’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.84 earnings per share. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Activity

In related news, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the sale, the chief financial officer now owns 6,614 shares of the company’s stock, valued at $700,422.60. This represents a 78.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the sale, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at $4,714,534.08. This represents a 72.01 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 256,373 shares of company stock valued at $27,637,427. 2.00% of the stock is owned by company insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.